Holen Sie sich die Stockscreener-App
54.05
0.28%
-0.155
Finanzdaten der Akero Therapeutics Inc-Aktie (AKRO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
0.45%
69.25
|
69.57 | 69.29 | 72.23 | 55.32 |
| Interest Income/Expense |
1.56%
1.172
|
1.154 | 1.20 | 1.246 | 1.231 |
| Operating Income/Loss |
0.01%
-80.87
|
-80.88 | -78.03 | -81.70 | -65.74 |
| Income/Loss From Continuing Operations Before Tax |
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
| Income/Loss From Continuing Operations After Tax |
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
Net Income/Loss
|
0.31%
-70.50
|
-70.72 | -70.02 | -72.70 | -55.99 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3.90%
81.72
|
78.66 | 1.154 | 69.44 | 69.16 |
| Diluted Average Shares |
3.90%
81.72
|
78.66 | 1.154 | 69.44 | 69.16 |
| Basic Earnings Per Share |
4.44%
-0.86
|
-0.90 | -0.99 | -1.05 | -0.81 |
| Diluted Earnings Per Share |
4.44%
-0.86
|
-0.90 | -0.99 | -1.05 | -0.81 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.68%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):